EP4043551A1 - Nährmedien mit pflanzenproteinhydrolysaten für zellkultur - Google Patents
Nährmedien mit pflanzenproteinhydrolysaten für zellkultur Download PDFInfo
- Publication number
- EP4043551A1 EP4043551A1 EP21156945.4A EP21156945A EP4043551A1 EP 4043551 A1 EP4043551 A1 EP 4043551A1 EP 21156945 A EP21156945 A EP 21156945A EP 4043551 A1 EP4043551 A1 EP 4043551A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- plant
- hydrolysate
- acid
- dry matter
- bran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title abstract description 11
- 238000004113 cell culture Methods 0.000 title abstract description 9
- 239000003531 protein hydrolysate Substances 0.000 title abstract description 6
- 235000021118 plant-derived protein Nutrition 0.000 title description 4
- 108010064851 Plant Proteins Proteins 0.000 title description 2
- 235000013305 food Nutrition 0.000 claims abstract description 88
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 235000013372 meat Nutrition 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 80
- 241000196324 Embryophyta Species 0.000 claims description 78
- 239000000413 hydrolysate Substances 0.000 claims description 58
- 239000000203 mixture Substances 0.000 claims description 45
- 239000000835 fiber Substances 0.000 claims description 28
- 235000007164 Oryza sativa Nutrition 0.000 claims description 25
- 235000009566 rice Nutrition 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 23
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- 235000004240 Triticum spelta Nutrition 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 235000015099 wheat brans Nutrition 0.000 claims description 8
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 7
- 235000009973 maize Nutrition 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000004458 spent grain Substances 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 235000010755 mineral Nutrition 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 240000006677 Vicia faba Species 0.000 claims description 4
- 235000010749 Vicia faba Nutrition 0.000 claims description 4
- 235000002098 Vicia faba var. major Nutrition 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 241000219146 Gossypium Species 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- 240000004713 Pisum sativum Species 0.000 claims description 3
- 235000010582 Pisum sativum Nutrition 0.000 claims description 3
- 239000012670 alkaline solution Substances 0.000 claims description 3
- 235000021120 animal protein Nutrition 0.000 claims description 3
- 239000002198 insoluble material Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
- 229930064664 L-arginine Natural products 0.000 claims description 2
- 235000014852 L-arginine Nutrition 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- 235000019393 L-cystine Nutrition 0.000 claims description 2
- 239000004158 L-cystine Substances 0.000 claims description 2
- 229930182816 L-glutamine Natural products 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- 239000004395 L-leucine Substances 0.000 claims description 2
- 235000019454 L-leucine Nutrition 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- 229930195722 L-methionine Natural products 0.000 claims description 2
- 229930182821 L-proline Natural products 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
- 229960001231 choline Drugs 0.000 claims description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- 229960002743 glutamine Drugs 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims description 2
- 229960004452 methionine Drugs 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 229960003581 pyridoxal Drugs 0.000 claims description 2
- 235000008164 pyridoxal Nutrition 0.000 claims description 2
- 239000011674 pyridoxal Substances 0.000 claims description 2
- 235000008160 pyridoxine Nutrition 0.000 claims description 2
- 239000011677 pyridoxine Substances 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229960001153 serine Drugs 0.000 claims description 2
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- 229960004441 tyrosine Drugs 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 3
- 235000012041 food component Nutrition 0.000 abstract description 10
- 210000003527 eukaryotic cell Anatomy 0.000 abstract description 6
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 241000209094 Oryza Species 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 19
- 239000002609 medium Substances 0.000 description 19
- 239000006143 cell culture medium Substances 0.000 description 14
- 239000000284 extract Substances 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000012092 media component Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 101100377809 Arabidopsis thaliana ABC1K3 gene Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 101100135806 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PCP1 gene Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
- 101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 102000044890 human EPO Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000001665 muscle stem cell Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/001—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from waste materials, e.g. kitchen waste
- A23J1/005—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from waste materials, e.g. kitchen waste from vegetable waste materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/006—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from vegetable materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/12—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from cereals, wheat, bran, or molasses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/14—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/18—Vegetable proteins from wheat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
Definitions
- the present invention relates to nutritional components suitable for cell culture of eukaryotic cells. These nutritional components can be prepared from plant-based protein hydrolysates.
- the invention further relates to nutrient media comprising these nutritional components.
- the nutrient media of the invention can be prepared by replacing serum components, which are common in such media, - at least partially - by the nutritional components of the invention.
- the nutritional components and the nutrient media of the invention are particularly suitable for use in the food industry, such as in the production of cultured meat.
- WO 98/15614 A1 describes cell culture medium formulations for the in vitro cultivation of animal cells. These media formulations comprise at least one plant-derived peptide and/or at least one plant-derived lipid and/or at least one plant-derived fatty acid. Rice, soy, potato, and corn are named as suitable sources of proteins, peptides, lipids, and/or fatty acids. Wheat is specifically excluded as a source of plant-derived proteins.
- the plant peptides to be used in the formulations of WO 98/15614 A1 may be prepared by digesting plant extracts with enzymes such as trypsin or chymotrypsin. The plant peptides are to be added to the basal medium at concentrations of about 10 - 1000 mg/liter.
- WO 03/045995 A2 describes the cost-effective production of recombinant glycoproteins such as human erythropoietin using a serum-free culture medium.
- the culture medium comprises a plant-derived peptone.
- the examples of WO 03/045995 A2 show a serum-free adaptation medium and a serum-free production medium. Each one of these two media contains 0.25% soya-peptone.
- US 9,714,411 B2 describes animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate.
- the total concentration of the plant- and/or yeast-derived protein hydrolysate in the cell culture medium is about 0.05% to about 5% (w/v).
- the plant-derived protein hydrolysate may be selected from a cereal hydrolysate and/or a soy hydrolysate.
- US 9,714,411 B2 defines the term "hydrolysate" as relating to any enzymatic digest of a vegetable or yeast extract.
- JP2013-247927 A discloses that a rice bran extract has a cell growth promoting action, when used in cell culture medium.
- the rice bran extract preferably comprises 50% by mass or more of protein.
- the rice bran extract may be a molecular weight fractionated product, preferably in the range between 3 kDa and 10kDa.
- JP2013-247927 A it was shown that a rice bran extract with a protein content of 55% improved proliferation of CHO cells when used in concentrations of 0.1 or 0.3 g/L, while cytotoxicity was observed at a concentration of 1 g/L.
- nutrient media for cell culture are a mixture of about 20 to 60 high grade and pure ingredients. The high number and the high purity of the ingredients renders such nutrient media very expensive.
- plant-based hydrolysates were used as additives for cell culture media.
- the plant-based extracts used in the prior art were obtained from isolated plant proteins or from protein-rich plant material, which can be grouped as primary food stream material.
- nutrient media components can be prepared using plant-based protein hydrolysates that were produced from secondary food stream material, i.e. material having lower economic value than primary food stream material.
- novel composition containing plant-based hydrolysates prepared from secondary food stream are much cheaper than the media ingredients of the prior art.
- These novel compositions can be used as media components and support the growth of eukaryotic cells, and can even be used in the production of cultured meat.
- the components and compositions of the present invention can be used for cell cultivation in an industrial scale.
- the present invention relates to a composition
- a composition comprising:
- the present invention relates to a use of the composition according to the first aspect in the production of cultured meat.
- the present invention relates to a method for the production of a plant-based hydrolysate obtained from secondary food stream material, comprising the steps:
- the present invention relates to a plant-based hydrolysate obtainable by the method of the third aspect.
- the present invention relates to a method for the production of the composition of the first aspect, comprising the step(s):
- the expression material from "primary food stream” refers to plant material that is suitable for human consumption. This material is characterized by high protein content (at least 30% (w/w dry matter) but typically at least 50% (w/w dry matter)) and low fibre content (5% or less (w/w dry matter), but typically 1% or less (w/w dry matter)).
- primary food stream material include, without limitation, protein-rich material derived from soy, fava bean, wheat (e.g. wheat gluten), rice, pea, potato, or cotton seed.
- secondary food stream refers to plant material that is generally not used for human consumption. Material from secondary food stream is mostly used as animal feed, as fertilizer or is simply burnt. As compared to material from primary food stream, secondary food stream material has a lower protein content (4% to 35%, and typically 10% to 30% (w/w dry matter)) and a higher fibre content (1% to 50%, and typically 10% to 20% (w/w dry matter)). Examples of secondary food stream material include, without limitation, rice bran, defatted rice bran, wheat bran, rye bran, maize bran, spelt bran, or brewer's spent grain.
- a “growth factor” refers to a protein or a peptide that promotes proliferation of eukaryotic cells in cell culture.
- growth factors usable in the present invention include, without limitation insulin and insulin-like growth factors (IGF).
- a protein content of "about 10% (w / w dry matter)" encompasses a protein content ranging from 9.5% (w/w dry matter) to about 10.5% (w/w dry matter).
- a temperature of "about 80°C” refers to a temperature range between 76°C and 84°C.
- the present invention is directed to a composition
- a composition comprising:
- the secondary food stream material has a protein content ranging from about 5% to about 34%; preferably from about 6% to about 33%, preferably from about 7% to about 32%, preferably from about 8% to about 31%, preferably from about 9% to about 30%, preferably from about 10% to about 29%, preferably from about 11% to about 28%, preferably from about 12% to about 27%, preferably from about 13% to about 26%, preferably from about 14% to about 25%, and most preferably from about 15% to about 25% (w/w dry matter).
- the secondary food stream material has a fibre content ranging from about 2% to about 45%, preferably from about 3% to about 40%, preferably from about 4% to about 35%, preferably from about 5% to about 30%, and most preferably from about 6% to about 25% (w/w dry matter).
- the secondary food stream material is or is prepared from rice bran, wheat bran, rye bran, maize bran, spelt bran, or brewer's spent grain.
- the secondary food stream material is or is prepared from
- the first plant-based hydrolysate is present in the composition in a concentration in the range from 0.1% to 50% (w/w).
- the food grade premix is present in the composition in a concentration in the range from 10% to 99.9% (w/w).
- composition further comprises:
- the primary food stream material has a protein content of at least 32%, preferably at least 34%, preferably at least 36%, preferably at least 38%, preferably at least 40%, preferably at least 42%, preferably at least 44%, preferably at least 46%, preferably at least 48, and most preferably at least 50% (w/w dry matter).
- the primary food stream material has a fibre content of 4% (w/w dry matter) or less, preferably 3% (w/w dry matter) or less, preferably 2% (w/w dry matter) or less, and most preferably 1% (w/w dry matter) or less.
- the second plant-based hydrolysate prepared from primary food stream material has been prepared from soy bean, fava bean, wheat, rice, pea, potato, or cotton seed.
- the second plant-based hydrolysate obtained from primary food stream is present in a concentration in the range from 0.1% to 50% (w/w).
- the second plant-based hydrolysate obtained from primary food stream was prepared by applying the method of the third aspect. This means that a plant-based material obtained from primary food stream, as defined above, is provided and that then steps (b) to (g) of the method of the third aspect are carried out.
- the composition according to the first aspect is used as a replacement of cell culture medium.
- An aqueous solution of the composition according to the first aspect can be prepared, thereby obtaining a plant-based medium.
- This plant-based medium can be used to partially replace a standard cell culture medium. For example, from about 100 mL to about 500 mL (preferably from about 150 mL to about 450 mL, preferably from about 200 mL to about 400 mL, more preferably from about 250 mL to about 350 mL, even more preferably about 300 mL) are removed from 1 L of a standard cell culture medium and the same volume of the plant-based medium as the volume that was removed is added to the remaining volume of standard cell culture medium as a replacement. For example, 300 mL are removed from 1 L of a standard cell culture medium and 300 mL of the plant-based medium are added to the remaining 700 mL as a replacement.
- the composition according to the first aspect is used as the starting material for the preparation of a cell culture medium.
- further components salts, buffer, energy sources (e.g. glucose), trace minerals, essential amino acids, growth factors) can then be added.
- Osmolality and pH can be adjusted.
- a person skilled in the art will be well-aware which further components, which pH and which osmolality will be suitable to promote growth of eukaryotic cells.
- the present invention is directed to a use of the composition according to the first aspect in the production of cultured meat.
- a method for the production of cultured meat comprising the steps:
- the sterile aqueous solvent is selected from the group consisting of water, phosphate buffer, and a solution of sodium chloride.
- the appropriate cells are selected from the group consisting of myosatellite cells, mesenchymal stromal cells, fibroblast cells, muscle cells, stem cells, and induced pluripotent stem cells (iPSCs).
- the appropriate cells are bovine cells, porcine cells or chicken cells.
- stem cells are human embryonic stem cells
- these human embryonic stem cells were prepared by a process that does not require the destruction of the human embryo.
- a person skilled in the art of producing cultured meat will be well aware which temperature ranges and which time-periods are required for obtaining cultured meat, taking into consideration the type of cells and the amount of cells used for inoculation.
- the present invention is directed to a method for the production of a plant-based hydrolysate obtained from secondary food stream, comprising the steps:
- the plant-based material obtained from secondary food stream has a protein content ranging from about 5% to about 34%; preferably from about 6% to about 33%, preferably from about 7% to about 32%, preferably from about 8% to about 31%, preferably from about 9% to about 30%, preferably from about 10% to about 29%, preferably from about 11% to about 28%, preferably from about 12% to about 27%, preferably from about 13% to about 26%, preferably from about 14% to about 25%, and most preferably from about 15% to about 25% (w/w dry matter).
- the plant-based material obtained from secondary food stream has a fibre content ranging from about 2% to about 45%, preferably from about 3% to about 40%, preferably from about 4% to about 35%, preferably from about 5% to about 30%, and most preferably from about 6% to about 25% (w/w dry matter).
- the plant-based material obtained from secondary food stream is or is obtained from rice bran, wheat bran, rye bran, maize bran, spelt bran, or brewer's spent grain.
- the plant-based material obtained from secondary food stream is or is prepared from
- the acid added in step (b) is a concentrated solution of HCl.
- the concentration of HCl is in the range from 0.1 M to 2 M, more preferably in the range from 0.2 M to 1.5 M, more preferably in the range from 0.3 M to 1 M, even more preferably in the range from 0.4 M to about 0.75 M, and most preferably at about 0.5 M.
- the incubation of step (c) is carried out at a temperature in the range between 61°C and 99°C, preferably at a temperature in the range between 62°C and 98°C, preferably at a temperature in the range between 63°C and 97°C, preferably at a temperature in the range between 64°C and 96°C, preferably at a temperature in the range between 65°C and 95°C, preferably at a temperature in the range between 66°C and 94°C, preferably at a temperature in the range between 67°C and 93°C, preferably at a temperature in the range between 68°C and 92°C, preferably at a temperature in the range between 69°C and 91°C, preferably at a temperature in the range between 70°C and 90°C, preferably at a temperature in the range between 71°C and 89°C, preferably at a temperature in the range between 72°C and 88°C, preferably
- step (c) is carried out for a time period between 12 hours and 48 hours, preferably between 15 hours and 36 hours, more preferably between 18 hours and 30 hours, and most preferably for about 24 hours.
- step (e) is carried out for about 5 min to about 20 min at about 4000 to 6000 x g, preferably for about 10 min to 15 min at about 4500 to about 5500 x g; most preferably for about 10 min at about 5250 x g.
- the sterile filter is a filter with a pore size of 50 ⁇ m or less, preferably 20 ⁇ m or less, more preferably 10 ⁇ m or less, and even more preferably, 0.2 ⁇ m or less.
- filtration steps with increasingly smaller pore sizes are used; e.g. a first filtration step with a filter having a pore size of 50 ⁇ m or less, a second filtration step with a filter having a pore size of 20 ⁇ m or less, a third filtration step with a filter having a pore size of 10 ⁇ m or less, and a fourth filtration step with a filter having a pore size of 0.2 ⁇ m or less.
- the method of the third aspect and its preferred embodiments are also suitable for producing a plant-based hydrolysate obtained from primary food stream when using a plant-based material obtained from primary food stream as starting material.
- the present invention is directed to a plant-based hydrolysate obtainable by the method of the third aspect.
- the plant-based hydrolysate has been obtained by the method of the third aspect.
- the present invention is directed to a method for the production of the composition of the first aspect, comprising the step(s):
- the plant-based hydrolysate prepared from secondary food stream is obtainable by the method of the third aspect.
- the plant-based hydrolysate prepared from secondary food stream has been obtained by the method of the third aspect.
- the secondary food stream material is as defined in the embodiments of the first aspect.
- the food grade premix is defined as in the embodiments of the first aspect of the invention.
- the primary food stream material is as defined in the embodiments of the first aspect.
- Fig. 1 shows a cell culture experiment with CHO cells.
- CHO cells were grown in reference medium or in media, in which components of the reference medium were replaced by a hydrolysate of defatted rice bran (RBD) (20% protein content). Two different lots of RBD hydrolysate were tested. At each day of cultivation, viable cell density (in 10 6 cells/mL) and viability of cells were recorded for each experiment.
- RBD defatted rice bran
- the plant material (either from primary food stream or from secondary food stream) was hydrolysed using the following protocol:
- Plant hydrolysates were prepared from the following starting materials (protein content is indicated in brackets): rye bran (17.1%), wheat bran (14.3%), fava bean (66%), spelt bran (19.7%), legria (21.2%), stabilized rice bran (15.1%), and defatted rice bran (19.0%).
- CHO-K1 cells Chinese hamster ovary cell line, subclone K1 Reference medium Liquid SBF medium, obtainable from Xell AG (Bielefeld, Germany) upon request under the product number 2052-0001
- CHO-K1 cells were grown in reference medium or in a medium containing a replacement with a hydrolysate of defatted rice bran (RBD) (20% protein content).
- RBD defatted rice bran
- the hydrolysates of defatted rice bran had been prepared according to the acid hydrolysis protocol described in Example 1 above. Two different lots of RBD hydrolysate were tested.
- Reference medium 1:3 means that 300 mL per 1 L of reference medium were replaced by distilled water.
- RBD and RBD1 both refer to a medium composition, in which 300 mL of defatted rice bran medium were added to 700 mL reference medium.
- Glucose concentration in all media variants was adjusted to either 4.5 g/L (for RBD and RBD1) or 6.2 g/L (for Reference 1:3), depending of glucose concentration of the food grade materials used.
- Glutamine was added to a final concentration of 6 mM.
- Cells were cultivated in 125 mL plain shake flasks with a working volume of 50 mL (in growth curves) in a 37°C incubator with an atmosphere of 5 % CO 2 .
- the maximum cell density was lower when using a medium containing a replacement of rice bran hydrolysate (about 4 x 10 6 cells/mL for the first lot; about 3.5 x 10 6 cells/mL for the second lot) as compared to the reference medium (5 x 10 6 cells/mL).
- maximum cell density was reached only after longer cultivation times (at day 7 for the first lot; at day 8 for the second lot) as compared to the reference medium (at day 6).
- the above results provide a proof of principle that a hydrolysate from rice bran (i.e. from a secondary food stream material) can be used as a supplement in cell culture media and supports the growth of eukaryotic cells.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21156945.4A EP4043551A1 (de) | 2021-02-12 | 2021-02-12 | Nährmedien mit pflanzenproteinhydrolysaten für zellkultur |
IL304952A IL304952A (en) | 2021-02-12 | 2022-02-09 | Nutrient media for cell culture that includes plant protein hydrolysates |
CN202280013969.5A CN116829694A (zh) | 2021-02-12 | 2022-02-09 | 用于细胞培养的包含植物蛋白水解物的营养培养基 |
AU2022219484A AU2022219484A1 (en) | 2021-02-12 | 2022-02-09 | Nutrient media for cell culture containing plant protein hydrolysates |
CA3206235A CA3206235A1 (en) | 2021-02-12 | 2022-02-09 | Nutrient media for cell culture containing plant protein hydrolysates |
KR1020237028436A KR20230135123A (ko) | 2021-02-12 | 2022-02-09 | 식물 단백질 가수분해물을 함유하는 세포 배양용 영양배지 |
PCT/EP2022/053163 WO2022171696A1 (en) | 2021-02-12 | 2022-02-09 | Nutrient media for cell culture containing plant protein hydrolysates |
US18/276,886 US20240043795A1 (en) | 2021-02-12 | 2022-02-09 | Nutrient media for cell culture containing plant protein hydrolysates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21156945.4A EP4043551A1 (de) | 2021-02-12 | 2021-02-12 | Nährmedien mit pflanzenproteinhydrolysaten für zellkultur |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4043551A1 true EP4043551A1 (de) | 2022-08-17 |
Family
ID=74595223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21156945.4A Pending EP4043551A1 (de) | 2021-02-12 | 2021-02-12 | Nährmedien mit pflanzenproteinhydrolysaten für zellkultur |
Country Status (8)
Country | Link |
---|---|
US (1) | US20240043795A1 (de) |
EP (1) | EP4043551A1 (de) |
KR (1) | KR20230135123A (de) |
CN (1) | CN116829694A (de) |
AU (1) | AU2022219484A1 (de) |
CA (1) | CA3206235A1 (de) |
IL (1) | IL304952A (de) |
WO (1) | WO2022171696A1 (de) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998015614A1 (en) | 1996-10-10 | 1998-04-16 | Life Technologies, Inc. | Animal cell culture media comprising plant-derived nutrients |
WO2003045995A2 (en) | 2001-11-28 | 2003-06-05 | Sandoz Gmbh | Cell culture process |
US20060286668A1 (en) * | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
JP2013247927A (ja) | 2012-06-01 | 2013-12-12 | Univ Of Fukui | 米糠由来の細胞増殖促進剤 |
US9714411B2 (en) | 2004-10-29 | 2017-07-25 | Baxalta GmbH | Animal protein-free media for cultivation of cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110101782A (ko) * | 2010-03-09 | 2011-09-16 | 씨제이제일제당 (주) | 미강 펩톤을 포함하는 미생물 배양용 조성물 |
-
2021
- 2021-02-12 EP EP21156945.4A patent/EP4043551A1/de active Pending
-
2022
- 2022-02-09 US US18/276,886 patent/US20240043795A1/en active Pending
- 2022-02-09 KR KR1020237028436A patent/KR20230135123A/ko active Search and Examination
- 2022-02-09 IL IL304952A patent/IL304952A/en unknown
- 2022-02-09 AU AU2022219484A patent/AU2022219484A1/en active Pending
- 2022-02-09 CN CN202280013969.5A patent/CN116829694A/zh active Pending
- 2022-02-09 CA CA3206235A patent/CA3206235A1/en active Pending
- 2022-02-09 WO PCT/EP2022/053163 patent/WO2022171696A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998015614A1 (en) | 1996-10-10 | 1998-04-16 | Life Technologies, Inc. | Animal cell culture media comprising plant-derived nutrients |
US20060286668A1 (en) * | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
WO2003045995A2 (en) | 2001-11-28 | 2003-06-05 | Sandoz Gmbh | Cell culture process |
US9714411B2 (en) | 2004-10-29 | 2017-07-25 | Baxalta GmbH | Animal protein-free media for cultivation of cells |
JP2013247927A (ja) | 2012-06-01 | 2013-12-12 | Univ Of Fukui | 米糠由来の細胞増殖促進剤 |
Non-Patent Citations (3)
Title |
---|
HANSAWASDI CHANIDA ET AL: "Potential Prebiotic Oligosaccharide Mixtures from Acidic Hydrolysis of Rice Bran and Cassava Pulp", PLANTS FOODS FOR HUMAN NUTRITION, KLUWER ACADEMIC PUBLISHERS, NL, vol. 72, no. 4, 3 October 2017 (2017-10-03), pages 396 - 403, XP036377921, ISSN: 0921-9668, [retrieved on 20171003], DOI: 10.1007/S11130-017-0636-Z * |
JARUNRATTANASRI ARPORN ET AL: "Aroma Components of Acid-Hydrolyzed Vegetable Protein Made by Partial Hydrolysis of Rice Bran Protein", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 55, no. 8, 1 April 2007 (2007-04-01), US, pages 3044 - 3050, XP055823220, ISSN: 0021-8561, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/jf0631474> DOI: 10.1021/jf0631474 * |
SATOSHI TERADA ET AL: "Culture supplement extracted from rice bran for better serum-free culture", BMC PROCEEDINGS, BIOMED CENTRAL LTD, LONDON UK, vol. 7, no. Suppl 6, 4 December 2013 (2013-12-04), pages P104, XP021170293, ISSN: 1753-6561, DOI: 10.1186/1753-6561-7-S6-P104 * |
Also Published As
Publication number | Publication date |
---|---|
WO2022171696A1 (en) | 2022-08-18 |
CN116829694A (zh) | 2023-09-29 |
CA3206235A1 (en) | 2022-08-18 |
AU2022219484A1 (en) | 2023-08-10 |
KR20230135123A (ko) | 2023-09-22 |
IL304952A (en) | 2023-10-01 |
US20240043795A1 (en) | 2024-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101362805B1 (ko) | 개선된 세포 배양 배지 | |
KR102109463B1 (ko) | 소형 펩티드를 포함하는 세포 배양 배지 | |
AU744715B2 (en) | Culture medium for culture of animal cell and method for producing protein using same | |
CN101864393A (zh) | 一种用于Vero细胞微载体培养的无动物来源成分无血清培养基 | |
CN105255810A (zh) | 一种适合昆虫细胞Sf-9的无血清无动物源培养基 | |
CN110418837B (zh) | 包含寡肽的培养基 | |
CA2383460C (en) | Metal binding compounds and their use in cell culture medium compositions | |
CN101245335A (zh) | 无血清植物蛋白肽通用细胞培养基 | |
EP4043551A1 (de) | Nährmedien mit pflanzenproteinhydrolysaten für zellkultur | |
Lobo-Alfonso et al. | Benefits and Limitations of Protein Hydrolysates as Components of Serum-Free Media for Animal Cell Culture Applications: Protein Hydrolysates in Serum Free Media | |
RU2377295C1 (ru) | Питательная среда для культивирования клеток млекопитающих | |
JP2024515337A (ja) | 細胞増殖培地の製造方法及び製造システム | |
JP2021503290A (ja) | 液体培地を作製するための合理化された方法 | |
Amirvaresi et al. | Evaluation of Plant-and Microbial-Derived Protein Hydrolysates as Substitutes for Fetal Bovine Serum in Cultivated Seafood Cell Culture Media | |
RU2023123428A (ru) | Питательные среды для культивирования клеток, содержащие гидролизаты растительных белков | |
WO2023225686A1 (en) | Supplemented serum-free media including unhydrolyzed plant protein for cultured meat production | |
CN117778301A (zh) | 一种无血清培养基及其在细胞培养肉中的应用 | |
IE913346A1 (en) | Media for culture of insect cells | |
CN116478914A (zh) | 无血清细胞培养体系及其细胞消化终止液 | |
CZ33033U1 (cs) | Živná složka kultivačních médií pro mikroorganismy | |
Ovissipour et al. | Assessment of Plant-and Microbial-Derived Protein Hydrolysates as Sustainable for Fetal Bovine Serum in Seafood Cell Culture Media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20210212 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230523 |